H.C. Wainwright recently cut its $IREN price target from $74 to $56 following the latest earnings, although it maintained its Buy rating.

Another thing worth watching is the delay in IREN's $4 billion ARR target. What was initially expected by December 2026 has now been pushed to January 2027, with February also a possibility due to customer-requested network design changes and supplier timing issues.

I'm still watching a few things before changing my bullish outlook. IREN continues to expect around $6 billion in additional funding sources to support its remaining FY2027 capital expenditure.

The concern for me is how the company manages that expansion without putting too much pressure on shareholders through further dilution or debt. The investment only makes sense if the revenue growth eventually justifies the capital being deployed.

One thing I've learned from following the stock market is that opportunities don't disappear just because sentiment changes. Markets keep moving, but the investors who adapt, understand the risks and evolve.

#HuangRisksOusterOverReportedAffairWithSubordinate